搜索临床试验以:ADXS31-142
总计4507个结果
-
Massachusetts General Hospital完全的
-
Taiho Oncology, Inc.完全的
-
Merus N.V.Incyte Corporation招聘中
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of Alexion完全的
-
Oregon State UniversityNational Institute of Environmental Health Sciences (NIEHS); Pacific Northwest National Laboratory 和其他合作者完全的
-
Centre for Addiction and Mental HealthBrain & Behavior Research Foundation招聘中
-
Cancer Institute and Hospital, Chinese Academy...Beijing Shenogen Biomedical Co., Ltd未知
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤 | 难治性多发性骨髓瘤美国
-
Iovance Biotherapeutics, Inc.不再可用
-
Celgene完全的淋巴瘤 | 淋巴瘤,大 B 细胞,弥漫性 | 胶质母细胞瘤 | 多发性骨髓瘤 | 原发性中枢神经系统淋巴瘤 | 多效性通路修饰剂美国, 西班牙, 比利时, 法国, 意大利
-
Clinical Hospital Centre ZagrebSisters of Mercy University Hospital未知
-
Iovance Biotherapeutics, Inc.主动,不招人
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, Inc主动,不招人
-
Cara Therapeutics, Inc.完全的
-
Belfast Health and Social Care TrustQueen's University, Belfast; NHS Blood and Transplant; Northern Ireland Clinical Trials Unit招聘中
-
Beijing Shenogen Biomedical Co., LtdThe First Affiliated Hospital with Nanjing Medical University; Guilin Medical University, China 和其他合作者未知
-
The George InstituteBaxter Healthcare Corporation; Australian and New Zealand Intensive Care Society Clinical Trials...完全的
-
KeifeRx, LLCWorldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries Limited尚未招聘
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian Government Department...完全的
-
M.D. Anderson Cancer CenterArray BioPharma终止